Financial Summary (All financials)
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 |
| Revenues | 3.5 | 2.2 | 0.3 | 75.5 |
| Revenue growth | 56.4% | 577.4% | -99.6% | |
| Cost of goods sold | 1.3 | 1.4 | 0.3 | 0.0 |
| Gross profit | 2.2 | 0.8 | 0.0 | 75.5 |
| Gross margin | 63.5% | 36.0% | -2.4% | 100.0% |
| Sales and marketing | 6.0 | 2.0 | 1.1 | 2.0 |
| Research and development | 36.7 | 28.6 | 12.8 | 22.0 |
| General and administrative | 10.2 | 4.1 | 1.1 | 1.2 |
| EBIT | -47.7 | -33.3 | -15.0 | 25.1 |
| EBIT margin | -1357.2% | -1479.7% | -4505.4% | 33.3% |
| Pre-tax income | 40.5 | 58.1 | 15.6 | 25.6 |
| Income taxes | 0.0 | 0.0 | 0.0 | 51.2 |
| Tax rate | 0.0% | 0.0% | 0.0% | 200.0% |
| Net income | -40.5 | -58.1 | -15.6 | 25.6 |
| Net margin | -1151.4% | -2583.0% | -4706.3% | 33.9% |
| |
| Diluted EPS | ($0.59) | ($2.64) | ($1.70) | |
| Shares outstanding (diluted) | 68.5 | 22.0 | 9.2 | |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|